More pharmaceutical companies limit drug discounts to hospitals as 340B program scrutiny continues

Pfizer is reportedly joining 12 other pharmaceutical companies in limiting 340B discounts to hospitals contracting with pharmacies to distribute medications. This episode details the saga between pharmaceutical companies and hospitals over the 340B program which has come under scrutiny in recent years. Hospitals say the drugmakers move to limit discounts and Medicare's decision to cut reimbursement are cutting into savings used to fund charity care and specialty pharmacy programs.   This episode is a rerun and was originally published in November of 2021.  Hosted on Acast. See acast.com/privacy for more information.